'Eligibility challenges' derail specialized trial of GSK's Zejula in breast cancer
Fierce Pharma
APRIL 26, 2023
Eligibility challenges' derail specialized trial of GSK's Zejula in breast cancer fkansteiner Wed, 04/26/2023 - 13:19
Fierce Pharma
APRIL 26, 2023
Eligibility challenges' derail specialized trial of GSK's Zejula in breast cancer fkansteiner Wed, 04/26/2023 - 13:19
Fierce Pharma
APRIL 27, 2023
The Top Line': A special series on Narcan, the life-saving nasal spray tcarey Thu, 04/27/2023 - 15:30
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 29, 2022
For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency. Developing best-in-class speciality enzymes. Novozymes has a long legacy of enzyme discovery and the ability to genetically engineer these speciality enzymes to be superior.
Fierce Pharma
JULY 21, 2023
In this episode of 'The Top Line' we replay an important show from April 28, 2023 regarding Narcan. | This week on "The Top Line," we revisit an episode on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription.
Advertisement
As demand for advanced therapies increases, so does the need for more specialized supply chain support, as these products have strict transportation and handling requirements.
Fierce Pharma
SEPTEMBER 3, 2024
Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. Semnur Pharmaceuticals is following in its parent company Scilex's footsteps with a special purpose acquisition company (SPAC) merger.
Fierce Pharma
AUGUST 16, 2024
Even as supplies of Novo Nordisk’s immensely popular GLP-1 drugs Ozempic and Wegovy start to stabilize, the Danish drugmaker continues to announce manufacturing and capacity upgrades at a rapid cli | Novo Nordisk Pharmatech, a unit that specializes in producing drug ingredients, is spending 1.5
Speaker: Patrick Dempsey and Andrew Erpelding of ZoomInfo
Advanced search: Narrow the search to find candidates using specialized filters like education, and current company technologies. We have added 10's of millions of personal emails and mobile records. Basic search: Easily search using keywords, job title, location, industry, and more.
Advertisement
However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Advertiser: ZoomInfo
To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and promote omnichannel marketing.
Let's personalize your content